Cystic fibrosis in adults.

The aim of this cross-sectional retrospective study was to describe clinical and functional characteristics and the microbiological profile of an adult population with cystic fibrosis. The study was performed at the Pulmonary Diseases Service of the Hospital of the Medical School of the State University of Campinas. The charts of 54 adults (27 males, 27 females) with cystic fibrosis were reviewed. Demographic, clinical, and microbiological data were collected. Clinical and functional characteristics of patients with chronic Pseudomonas infection were compared with those without it. The mean age of the patients was 41.8 years and the mean sweat chloride concentration was 106.4 mEq/L. Forty-nine percent had chronic respiratory symptoms only after 18 years of age, and 85% reported chronic production of purulent sputum. Six percent had diarrhea or fat in stools, and no patient suffered from diabetes mellitus. Pseudomonas was present in 48%, and 73% of them had the mucoid strain. Others agents found were Staphylococcus aureus (28%), Hemophylus sp. (34%), Aspergillus sp. (22%), Stenotrophomonas maltophilia (9%), Acinetobacter sp. (7%), and Burkholderia cepacia (2%). Nontuberculous mycobacteria were found in sputum from 9 patients (11%); 34 patients (67%) had obstructive ventilatory defect; and 47% had obstruction and restriction. Concerning the groups with and without Pseudomonas colonization, only the values of sweat chloride were significantly higher in chronic colonized patients. Less severe phenotypes of cystic fibrosis may be found among patients previously diagnosed as having bronchiectasis. Chronic colonization with Pseudomonas aeruginosa in this study was not associated with worse clinical status but colonized patients did show significantly higher levels of chloride in sweat.

Wood charcoal and activated carbon dust pneumoconiosis in three workers.

BACKGROUND: Data on prevalence of lung diseases due to inhalation of carbonaceous materials other than mineral coal is very limited. METHODS: We present three cases of wood charcoal pneumoconiosis, two due to activated carbon, and one from wood charcoal artisan handling. To our knowledge, no clinical cases of wood charcoal pneumoconiosis, from artisan handling has been published so far. CLINICAL CASES: The three cases had their X rays classified by two B-readers as p/q round opacities with profusion ranging from 2/2 to 3/3. HRCT of two of them showed a diffuse centrilobular ground glass nodular pattern with subpleural small areas of consolidations. Transbronchial biopsies showed deposition of black pigment in the bronchiolar interstice similar to the histological appearance of simple coal workers pneumoconiosis, with no signs of fibrosis. Spirometry showed no abnormalities in the three cases. CONCLUSIONS: The authors point out to a probably underestimated respiratory occupational risk related to wood charcoal manipulation, which must be addressed mostly in developing countries, where deficient workplace conditions can lead to exposure above limit levels.

Pulmonary involvement in ankylosing spondylitis.

This is a prospective study analyzing 52 asymptomatic, consecutive patients with ankylosing spondylitis (AS), who submitted to a pulmonary investigation that included plain chest radiography, pulmonary function test (PFT), and thoracic high-resolution computed tomography (HRCT). The results were compared according to sex, race, dorsal spine involvement, thoracic diameter, smoking status, and HLA-B27. There were four patients (8%) with an altered plain chest radiograph. PFT presented a restrictive pattern in 52% of the patients. Thoracic HRCT showed abnormalities in 21 patients (40%), predominantly nonspecific linear parenchymal opacities (19%), lymphadenopathy (12%), emphysema (10%), bronchiectasis (8%), and pleural involvement (8%). Linear parenchymal opacities were associated with a smoking history (p=0.026) and dorsal spine involvement (p=0.032). HLA-B27 was not associated with any abnormality. A lower thoracic diameter was observed in patients with dorsal spine involvement (p=0.0001), restrictive pattern at PFT (p=0.023), and linear parenchymal opacities (p=0.015). The study concluded that nonspecific subclinical pulmonary involvement is frequent in AS.

Calcificação pulmonar metastática: correlação da tomografia computadorizada de alta resolução com a anatomopatologia / Metastatic pulmonary calcification: correlation of the high-resolution computed tomography with pathological findings

Introdução: esse artigo tem como objetivo correlacionar os achados na tomografia computadorizada de alta resolução de tórax com a anatomopatologia na calcificação pulmonar metastática. Metodologia: estudo retrospectivo das TCAR e do material anatomopatológico obtido por biópsia pulmonar em dois pacientes com calcificação pulmonar metastática. Resultados: um dos pacientes mostrou nódulos centrolobulares, com atenuação periférica em vidro fosco e calcificação central, que corresponderam na histopatologia à calcificação nos septos alveolares, com formação de aglomerados calcificados em algumas regiões. O outro apresentou como principal achado consolidações densas, que corresponderam à calcificações nos septos alveolares associadas a proliferação de tecido fibroso no interior dos espaços alveolares. Conclusão: a identificação na TCAR de nódulos em vidro fosco com calcificação central, ou de consolidações densas, faz com que a calcificação pulmonar metastática seja incluída entre as principais hipóteses diagnósticas.

Reversed halo sign in pulmonary paracoccidioidomycosis.

OBJECTIVE: The purpose of this study was to evaluate the prevalence of the reversed halo sign in pulmonary paracoccidioidomycosis. MATERIALS AND METHODS: The high-resolution CT scans (1- or 2-mm collimation scans) of 148 consecutive patients with proven pulmonary paracoccidioidomycosis were reviewed to determine the prevalence of the reversed halo sign in these patients. The reversed halo sign was defined as central ground-glass opacity surrounded by a crescent or ring of consolidation. The images were reviewed by two radiologists who reached a decision by consensus. RESULTS: A reversed halo sign was found in 15 patients (10%), including 13 men and two women ranging in age from 20 to 58 years (mean, 48 years). Three patients had only one reversed halo sign, one had two lesions, and the remaining had multiple lesions. The size of the sign ranged from 10 to 50 mm (average, 20 mm). In two cases the reversed halo sign was the only finding on CT. The most common associated findings seen in the remaining 13 patients included bilateral patchy areas of ground-glass attenuation (n = 10), parenchymal bands (n = 8), and small centrilobular nodules (n = 8). Three patients underwent surgical lung biopsy. Histologically the central area of the lesions consisted of an inflammatory infiltrate in the alveolar septa, composed of macrophages, lymphocytes, plasma cells, and some giant cells, with relative preservation of the alveolar spaces. The periphery of the lesion consisted of dense and homogeneous intraalveolar cellular infiltrate. There was no evidence of organizing pneumonia. CONCLUSION: The reversed halo sign is seen in approximately 10% of patients with paracoccidioidomycosis. In these patients, this sign reflects the presence of a central area of predominantly interstitial inflammation surrounded by predominantly air-space infiltration.

Unusual manifestations of metastatic pulmonary calcification: high-resolution CT and pathological findings.

The aim of this report is to describe the high-resolution CT and pathologic findings of 3 patients with unusual manifestations of metastatic pulmonary calcification. These include a case that presented with extensive dense consolidation, a case of metastatic calcification that improved spontaneously, and a case of metastatic calcification in a patient with no demonstrable biochemical abnormality or underlying disease. We conclude that metastatic calcification may present with dense bilateral consolidation, may improve spontaneously, and may rarely present in patients with no apparent underlying biochemical abnormality.